Drugs / Renshen Yangrong Tang
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03911921 | Jun 2015 → Feb 2019 | cancer-related condition | Peking University Cancer Hospital & Institute | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02053740 | Jan → Aug 2013 | immunodeficiency disease | Tri-Service General Hospital (TSGH) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Renshen Yangrong Tang | “Renshen Yangrong Tang (RSYRT), which is a mixture of 12 herbs, was commonly used as a pharmacological option in China for fatigue management by correcting Qi deficiency.” PMID 31668965 ↗ Oct 20191“Use of Traditional Chinese Medicine (Ren Shen Yang Rong Tang) Against Microinflammation in Hemodialysis Patients: A Quasi-randomized Controlled Trial” NCT02053740 ↗ |
| Known as | RSYRT | “Renshen Yangrong Tang (RSYRT), which is a mixture of 12 herbs, was commonly used as a pharmacological option in China for fatigue management by correcting Qi deficiency.” PMID 31668965 ↗ Oct 20191“The experimental group was treated with Ren Shen Yang Rong Tang (R-S-Y-R-T) combined routine western medicine, and the control group was treated with WM alone.” NCT02053740 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “herbal granules prepared according to the formula of R-S-Y-R-T.” NCT02053740 ↗ |